Lycopene for the treatment of metabolic dysfunction
AssigneeCammedica Limited
InventorsIvan Petyaev, George Bash
Life of this patent
Estimating the term…
Abstract
This invention relates to the treatment of metabolic dysfunction and disorders associated with metabolic dysfunction using lycopene compounds. Methods of treatment and uses of lycopene compounds in such methods are provided.
Claims31
1-85. (canceled)
A method of treating metabolic dysfunction or a condition associated with metabolic dysfunction, the method comprising:
- administering a lycopene compound in a therapeutically effective amount to an individual in need thereof.
A kit comprising a lycopene compound and a statin for use in combination to treat metabolic dysfunction or a condition associated with metabolic dysfunction.
A food product comprising a lycopene compound for treating metabolic dysfunction or a condition associated with metabolic dysfunction, wherein the lycopene compound is not naturally present in the food product.
A method of making a food product for treating metabolic dysfunction or a condition associated with metabolic dysfunction, the method comprising:
- (i) providing a food product ingredient,
- (ii) mixing a lycopene compound with said ingredient, and
- (iii) formulating said ingredient and said lycopene compound into a food product.
A method according to claim 1 12 wherein the food product is a bread, a cereal, a biscuit, butter, a spread, cheese, yogurt or a beverage.
A method according to claim 1 12 wherein the lycopene compound is lycopene.
A method according to claim 1 14 wherein the metabolic dysfunction is selected from obesity, insulin resistance, reduced glucose tolerance, polycystic ovary syndrome, hypertension, steatosis, chronic hepatitis, liver fibrosis, cirrhosis, and metabolic syndrome.
Dependencies are inferred from the claim text.